Latest News by Industry

Technology

Moody's credit rating upgrade for Cyprus opens the door to investment, president says

•

Nov 23, 2024

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

•

Nov 22, 2024

Supreme Court allows multibillion-dollar class action to proceed against Meta

•

Nov 22, 2024

Oil & Gas

ExxonMobil could partner up with Eni and Total to jointly develop natural gas deposits off Cyprus

•

Nov 22, 2024

Stock market today: Wall Street rises following last week's slide

•

Nov 18, 2024

What to know about Chris Wright, Trump's choice to run the Energy Department

•

Nov 18, 2024

Healthcare

Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys

•

Nov 12, 2024

Stock market today: Wall Street drifts lower as the Trump trade cools

•

Nov 12, 2024

Natera: Q3 Earnings Snapshot

•

Nov 12, 2024

Manufacturing

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

•

Nov 22, 2024

Stock market today: Wall Street rises with Nvidia as bitcoin bursts above $99,000

•

Nov 21, 2024

Nvidia is Wall Street's most valuable company. How it got there, by the numbers

•

Nov 21, 2024

Akebia Therapeutics, Inc. reports $26.2 million Q1 loss

By USInMinutes - May 08, 2023, 09:26 AM ET

Last Updated - Jul 18, 2023, 03:34 PM EDT

Akebia Therapeutics, Inc. reports $26.2 million Q1 loss

The company generated $40.10 million in quarterly revenue

Akebia Therapeutics, Inc. [AKBA] has reported fiscal Q1 loss of $26.20 million.

On a per-share basis, the DE based company said its diluted earnings are $0.14.

The Pharmaceutical Preparations firm posted revenue of $40.10 million in this period.

Also Read:

Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
Akebia Therapeutics to Report First Quarter Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics to Host Stockholder Information Session to Discuss Rationale for Reverse Stock Split
Akebia Therapeutics Announces Adjournment of Special Meeting of Stockholders
Akebia Therapeutics Announces Poster Presentations at National Kidney Foundation Spring Clinical Meetings 2023

NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.

Latest News by Industry

Technology

Show more

Moody's credit rating upgrade for Cyprus opens the door to investment, president says

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

Supreme Court allows multibillion-dollar class action to proceed against Meta

Oil & Gas

Show more

ExxonMobil could partner up with Eni and Total to jointly develop natural gas deposits off Cyprus

Stock market today: Wall Street rises following last week's slide

What to know about Chris Wright, Trump's choice to run the Energy Department

Healthcare

Show more

Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys

Stock market today: Wall Street drifts lower as the Trump trade cools

Natera: Q3 Earnings Snapshot

Manufacturing

Show more

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

Stock market today: Wall Street rises with Nvidia as bitcoin bursts above $99,000

Nvidia is Wall Street's most valuable company. How it got there, by the numbers

Akebia Therapeutics, Inc. reports $26.2 million Q1 loss

The company generated $40.10 million in quarterly revenue

Latest News

North Carolina GOP governor nominee vows to keep running after report on racial and sexual comments

A courtroom of relief: FBI recovers funds for victims of scammed banker

Here are the people Trump has picked for key positions so far

Finance Insurance & Real Estate

Show more

Bitcoin ticks closer to $100,000 in extended surge following US elections

Indigenous leaders travel to UK from Peru to draw attention to oil damage and banking

Rental home investors poised to benefit as mortgage rates, high home prices sideline buyers in 2025

Retail

Show more

Stock market today: Wall Street drifts as Target tumbles

A tale of two retailers: Target reports sluggish spending while Walmart has a stellar quarter

Target: Fiscal Q3 Earnings Snapshot

Transportation

Show more

Stock market today: Wall Street cruises to more records as it closes its best week in a year

Expedia: Q3 Earnings Snapshot

Virgin Galactic: Q3 Earnings Snapshot

Our Contact

Quick Links

Categories

Our Offices

10kInfo, Inc.

10kInfo Data Solutions, Pvt Ltd.

Akebia Therapeutics, Inc. reports $26.2 million Q1 loss

The company generated $40.10 million in quarterly revenue

'Wicked' and 'Gladiator' make gravity-defying theater debuts

The rising price of paying the national debt is a risk for Trump's promises on growth and inflation

Nigeria turns to natural gas as transport prices soar after petrol subsidies were removed

He'll be the last meatpacker in the Meatpacking District. Here's how NYC's gritty 'hood got chic

The rising price of paying the national debt is a risk for Trump's promises on growth and inflation

Here are the people Trump has picked for key positions so far

A $300B a year deal for climate cash at UN summit sparks outrage for some and hope for others

Nigeria turns to natural gas as transport prices soar after petrol subsidies were removed

Trump chooses Bessent to be treasury secretary, Vought as budget chief, Chavez-DeRemer for Labor

Trump taps a Fox News personality, a surgeon and a former Congressman to lead public health agencies

What to know about Lori Chavez-DeRemer, Trump's pick for labor secretary

GLOBAL X ANNOUNCES NOVEMBER 2024 DISTRIBUTIONS FOR ITS SUITE OF ETFs